385 related articles for article (PubMed ID: 16467658)
1. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
Schrader J; Lüders S; Kulschewski A; Hammersen F; Züchner C; Venneklaas U; Schrandt G; Schnieders M; Rangoonwala B; Berger J; Dominiak P; Zidek W;
J Hypertens; 2006 Mar; 24(3):541-8. PubMed ID: 16467658
[TBL] [Abstract][Full Text] [Related]
2. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
[TBL] [Abstract][Full Text] [Related]
3. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
4. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.
Azizi M; Ménard J; Peyrard S; Lièvre M; Marre M; Chatellier G
Diabetes Care; 2006 Jun; 29(6):1331-6. PubMed ID: 16732017
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
Hathial M
Indian Heart J; 2008; 60(3):200-4. PubMed ID: 19240307
[TBL] [Abstract][Full Text] [Related]
6. Microalbuminuria and hypertension.
Reboldi G; Gentile G; Angeli F; Verdecchia P
Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
[TBL] [Abstract][Full Text] [Related]
7. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
[TBL] [Abstract][Full Text] [Related]
8. The HOPE Study (Heart Outcomes Prevention Evaluation).
Sleight P
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
[TBL] [Abstract][Full Text] [Related]
9. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
10. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
Hathial M
J Indian Med Assoc; 2008 Jul; 106(7):468-70, 480. PubMed ID: 18975506
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).
Joshi SR; Yeolekar ME; Tripathi KK; Giri J; Maity AK; Chopda M; Gujarathi S; Maroli S; Maity A;
J Assoc Physicians India; 2004 Mar; 52():189-95. PubMed ID: 15636307
[TBL] [Abstract][Full Text] [Related]
13. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH.
Böhm M; Reil JC; Danchin N; Thoenes M; Bramlage P; Volpe M
J Hypertens; 2008 Jan; 26(1):18-25. PubMed ID: 18090536
[TBL] [Abstract][Full Text] [Related]
14. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
Marre M; Lievre M; Chatellier G; Mann JF; Passa P; Ménard J;
BMJ; 2004 Feb; 328(7438):495. PubMed ID: 14960504
[TBL] [Abstract][Full Text] [Related]
15. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
16. [Stress-associated hypertension in the work place: results of the STARLET project].
Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
[TBL] [Abstract][Full Text] [Related]
17. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring.
Uchaipichat V; Koanantakul B; Suthisisang C
J Med Assoc Thai; 2008 Sep; 91(9):1468-77. PubMed ID: 18843880
[TBL] [Abstract][Full Text] [Related]
18. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
[TBL] [Abstract][Full Text] [Related]
19. [Prediction, screening and treatment of renal complications of diabetes].
Marre M; Larger E
Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
[TBL] [Abstract][Full Text] [Related]
20. Effect of antihypertensive treatment on qualitative estimates of microalbuminuria.
Agrawal B; Wolf K; Berger A; Luft FC
J Hum Hypertens; 1996 Aug; 10(8):551-5. PubMed ID: 8895040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]